The only significant difference found by the meta-analysis was a small increase in myocardial infarction and eye disorders with sulfonylureas compared with dipeptidyl peptidase-4 inhibitors.
The findings underscore the urgency of early diagnosis of diabetes and the consequences of failing to achieve near-normal glycemia soon after patients are diagnosed, according to the study authors.
The studied risk factors were HbA1c level, LDL cholesterol level, presence of albuminuria, smoking status, and blood pressure.
The updated guideline from the World Health Organization (WHO) included five recommendations, some of which differed from ACP's most recent diabetes guideline.
The third edition of “Diabetes in America” is free and covers diabetes epidemiology, prevention, care, and complications.
The FDA has identified 12 cases of necrotizing fasciitis of the perineum or Fournier's gangrene. All 12 patients were hospitalized and required surgery, and one died.